NEW DELHI– Salt warning labels on menus in restaurants may help diners rethink high-salt meals and make healthier choices, according to a study. This approach could also be a key strategy to combat ...

Roche is heading to regulators after its blockbuster kidney disease candidate, Gazyva (obinutuzumab), met its primary endpoint during a Phase III trial in membranous nephropathy. In the 104-week, head ...

Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss drug Ozempic to include the reduction of kidney disease risk. The decision ...

Shares of Travere Therapeutics (TVTX) and Ligand Pharmaceuticals (LGND) traded higher in the premarket on Tuesday after the FDA approved a label expansion for their jointly developed kidney disease ...